Zobrazeno 1 - 10
of 20
pro vyhledávání: '"E. L Shkolnik"'
Publikováno v:
КардиоСоматика, Vol 4, Iss 4, Pp 20-24 (2013)
Recent years have seen significant progress in the treatment of many oncologicaldiseases associated with the development of new chemotherapeutic agents. Typically, they are used in combination with classical chemotherapy regimens that in-clude doxoru
Externí odkaz:
https://doaj.org/article/3e918cdb1e3f4e50ad05342ec304c0ee
Autor:
M. M. Shcherbak, E. L. Shkolnik, Yu. A. Vasyuk, E. N. Yushchuk, E. Yu. Trush, G. Burneykaite, E. Chelutkene, G. Yakutis, G. Zuoziene, B. Petrauskiene
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 18, Iss 5, Pp 17-22 (2019)
Aim. To evaluate effects of various protocols of cardiac shock wave therapy (CSWT) on quality of life and exercise tolerance in patients with stable angina against the background of optimal medication therapy (OMT).Material and methods. Overall 53 pa
Externí odkaz:
https://doaj.org/article/fed88cd9f93c4d7a89fc8bd4dceb8b01
Autor:
Yu. V. Vasyuk, V. V. Nesvetov, E. L. Shkolnik, L. D. Shkolnik, G. V. Varlan, G. E. Gendlin, E. I. Emelina
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 13, Iss 2, Pp 184-190 (2017)
Aim. To study the efficacy of ivabradine in the prevention of cardiotoxic effects due to chemotherapeutic drugs in patients with breast cancer. Material and methods. The open randomized uncontrolled study included 55 patients with breast cancer who h
Externí odkaz:
https://doaj.org/article/ac349014a6fe4c64b4fc8ed37404bd49
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 12, Pp 39-44 (2016)
Aim. To study the influence of various geometric models of the left ventricle (LV) on long-term prognosis in arterial hypertension (AH).Material and methods. Totally, 180 AH patients studied at the age 50,5±6,7 y.o., for 10 years of follow-up. All p
Externí odkaz:
https://doaj.org/article/40fbd56d9ede4db0beeeb05622be021b
Autor:
Yu. A. Vasyuk, S. V. Ivanova, E. L. Shkolnik, Yu. V. Kotovskaya, V. A. Milyagin, V. E. Oleynikov, Ya. A. Orlova, A. N. Sumin, A. A. Baranov, S. A. Boytsov, A. S. Galyavich, Zh. D. Kobalava, O. V. Kozhevnikova, A. O. Konradi, Yu. M. Lopatin, V. Yu. Mareev, D. S. Novikova, R. G. Oganov, A. N. Rogoza, O. P. Rotar, N. V. Sergatskaya, V. V. Skibitsky
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 15, Iss 2, Pp 4-19 (2016)
Recently, there was plenty studies published on the arterial stiffness assessment, and importance of this was proved as an independent prediction parameter, together with standard cardiovascular risk factors. In current document, we collect and struc
Externí odkaz:
https://doaj.org/article/7eb8446f6b144072abeda9f1b7bd83b8
Autor:
Yu. A. Vasyuk, E. L. Shkolnik
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 4, Pp 28-32 (2013)
Recently, echocardiography has been playing an increasing role in the diagnostics of cardiovascular disease. Qualitative assessment of heart chamber sizes, myocardial mass, systolic and diastolic function is one of the most important tasks of echocar
Externí odkaz:
https://doaj.org/article/08a4a2621c07402389198ad6c4e85392
Publikováno v:
European Heart Journal - Cardiovascular Imaging. 21
Funding Acknowledgements without financial supports Introduction Despite the high efficiency, the use of chemotherapeutic drugs involves to the development of cardiomyopathy and heart failure. Correction of myocardial damage is most effective before
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77db2fbeedc95b33add4876f274ae403
https://doi.org/10.1093/ehjci/jez319.223
https://doi.org/10.1093/ehjci/jez319.223
Autor:
L. D. Shkolnik, E. I. Emelina, Yu. V. Vasyuk, V. V. Nesvetov, E. L. Shkolnik, G. V. Varlan, G. E. Gendlin
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 13, Iss 2, Pp 184-190 (2017)
Aim. To study the efficacy of ivabradine in the prevention of cardiotoxic effects due to chemotherapeutic drugs in patients with breast cancer. Material and methods. The open randomized uncontrolled study included 55 patients with breast cancer who h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e86bbda83b5bf92915f554d8a9276932
https://www.rpcardio.com/jour/article/view/1443
https://www.rpcardio.com/jour/article/view/1443
Publikováno v:
Russian Heart Failure Journal. 17:383-387
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65a946c0e6271a60a39b3a102e6cb31e
https://doi.org/10.18087/rhfj.2016.6.2327
https://doi.org/10.18087/rhfj.2016.6.2327
Publikováno v:
Kardiologiia. 56(12)
Anthracyclines including doxorubicin, epirubicin, daunorubicin, aclarubicin are extensively used as chemotherapeutic agents for treatment of hematological and other malignancies. In cancer therapy anthracyclines are often used in combinations with ot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b951dec37fc7cf42760929b88e744a6c
https://pubmed.ncbi.nlm.nih.gov/28290807
https://pubmed.ncbi.nlm.nih.gov/28290807